...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

The question here is, what do the sellers know that the buyers don't when on the surface we know of the number of ZEN-3694 clinical trials (in collaboration with Big Pharma) that are ongoing?

Koo

Share
New Message
Please login to post a reply